Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations

J. C. Butler, R. F. Breiman, J. F. Campbell, H. B. Lipman, C. V. Broome and R. R. Facklam
Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333.

OBJECTIVE--To determine pneumococcal polysaccharide vaccine efficacy in selected populations at risk for serious pneumococcal infection for whom vaccination is currently recommended and to assess duration of protection after vaccination. DESIGN--Vaccine efficacy was estimated using indirect cohort analysis to compare the proportion of pneumococcal infections caused by serotypes included in the vaccines of vaccinated and unvaccinated persons who were identified during 14 years of national surveillance. SETTING--Hospital laboratories in the United States that submitted pneumococcal isolates to the Centers for Disease Control and Prevention between May 1978 and April 1992. PARTICIPANTS--A total of 2837 persons older than 5 years who had pneumococcus isolated from blood or cerebrospinal fluid. RESULTS--Overall efficacy for preventing infection caused by serotypes included in the vaccine was 57% (95% confidence interval [CI], 45% to 66%). Efficacy among persons with diabetes mellitus was 84% (95% CI, 50% to 95%); with coronary vascular disease, 73% (95% CI, 23% to 90%); with congestive heart failure, 69% (95% CI, 17% to 88%); with chronic pulmonary diseases, 65% (95% CI, 26% to 83%); and with anatomic asplenia, 77% (95% CI, 14% to 95%). Efficacy was not documented for patients with alcoholism or cirrhosis, sickle cell disease, chronic renal failure, lymphoma, leukemia, or multiple myeloma, although sample sizes were small for these groups. Efficacy for immunocompetent persons older than 65 years was 75% (95% CI, 57% to 85%). Efficacy did not decline with increasing interval after vaccination: 5 to 8 years after vaccination it was 71% (95% CI, 24% to 89%), and 9 years or more after vaccination it was 80% (95% CI, 16% to 95%). CONCLUSIONS--Intensified efforts to improve pneumococcal vaccine coverage among certain populations for whom vaccination is currently recommended is indicated, but universal revaccination is not warranted at this time.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Invasive Pneumococcal Disease Among White Mountain Apache Adults, 1991-2005
Bliss et al.
Arch Intern Med 2008;168:749-755.
ABSTRACT | FULL TEXT  

Effects of pneumococcal vaccine in patients with chronic respiratory disease
Watanuki et al.
ERR 2008;17:43-45.
ABSTRACT | FULL TEXT  

Pneumococcal Vaccination for Patients With COPD: Current Practice and Future Directions
Schenkein et al.
Chest 2008;133:767-774.
ABSTRACT | FULL TEXT  

Performance Measures, Vaccinations, and Pneumonia Rates Among High-Risk Patients in Veterans Administration Health Care
Jha et al.
Am. J. Public Health 2007;97:2167-2172.
ABSTRACT | FULL TEXT  

Functional Antibodies to the O-Acetylated Pneumococcal Serotype 15B Capsular Polysaccharide Have Low Cross-Reactivities with Serotype 15C
Rajam et al.
CVI 2007;14:1223-1227.
ABSTRACT | FULL TEXT  

Ten-Year Surveillance of Pneumococcal Infections in Temuco, Chile: Implications for Vaccination Strategies
Inostroza et al.
CVI 2007;14:660-664.
ABSTRACT | FULL TEXT  

Pneumococcal Capsular Polysaccharide Vaccine-Mediated Protection against Serotype 3 Streptococcus pneumoniae in Immunodeficient Mice
Tian et al.
Infect. Immun. 2007;75:1643-1650.
ABSTRACT | FULL TEXT  

Discovery of a New Capsular Serotype (6C) within Serogroup 6 of Streptococcus pneumoniae
Park et al.
J. Clin. Microbiol. 2007;45:1225-1233.
ABSTRACT | FULL TEXT  

The economic cost of invasive pneumococcal disease and the potential for reduction by vaccination in an adult population in South Yorkshire.
Parsons et al.
QJM 2006;99:348-349.
FULL TEXT  

Pneumonia in Older Adults: Reversing the Trend
File and Tan
JAMA 2005;294:2760-2763.
FULL TEXT  

Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects
Vila-Corcoles et al.
Eur Respir J 2005;26:1086-1091.
ABSTRACT | FULL TEXT  

Guidelines for the management of adult lower respiratory tract infections
Woodhead et al.
Eur Respir J 2005;26:1138-1180.
ABSTRACT | FULL TEXT  

Immunization with Recombinant Streptococcus pneumoniae Neuraminidase NanA Protects Chinchillas against Nasopharyngeal Colonization
Tong et al.
Infect. Immun. 2005;73:7775-7778.
ABSTRACT | FULL TEXT  

Pneumococcal sepsis in patients with systemic lupus erythematosus
Naveau and Houssiau
Lupus 2005;14:903-906.
ABSTRACT  

Antibiotics for Life-Threatening Illness
Hara and Stone
Journal of Pharmacy Practice 2005;18:336-350.
ABSTRACT  

Splenic Arterial Interventions: Anatomy, Indications, Technical Considerations, and Potential Complications
Madoff et al.
RadioGraphics 2005;25:S191-S211.
ABSTRACT | FULL TEXT  

Multiplex PCR for Identification of Seven Streptococcus pneumoniae Serotypes Targeted by a 7-Valent Conjugate Vaccine
O'Halloran and Cafferkey
J. Clin. Microbiol. 2005;43:3487-3490.
ABSTRACT | FULL TEXT  

An economic analysis of a pneumococcal vaccine programme in people aged over 64 years in a developed country setting
Mangtani et al.
Int J Epidemiol 2005;34:565-574.
ABSTRACT | FULL TEXT  

Asthma as a Risk Factor for Invasive Pneumococcal Disease
Talbot et al.
NEJM 2005;352:2082-2090.
ABSTRACT | FULL TEXT  

Approach to Validating an Opsonophagocytic Assay for Streptococcus pneumoniae
Hu et al.
CVI 2005;12:287-295.
ABSTRACT | FULL TEXT  

Immunization with Native or Recombinant Streptococcus pneumoniae Neuraminidase Affords Protection in the Chinchilla Otitis Media Model
Long et al.
Infect. Immun. 2004;72:4309-4313.
ABSTRACT | FULL TEXT  

Potential Impact of Conjugate Pneumococcal Vaccines on Pediatric Pneumococcal Diseases
O'Brien and Santosham
Am J Epidemiol 2004;159:634-644.
ABSTRACT | FULL TEXT  

An audit of splenectomies in a teaching hospital in North India. Are postsplenectomy guidelines being complied with?
Deodhar and Kakkar
J. Clin. Pathol. 2004;57:407-410.
ABSTRACT | FULL TEXT  

Pneumococcal vaccination for RA patients on TNF-{alpha} antagonists
Wright and Taggart
Rheumatology (Oxford) 2004;43:523-523.
FULL TEXT  

Management of Chronic Obstructive Pulmonary Disease--Reply
Sin et al.
JAMA 2004;291:1067-1067.
FULL TEXT  

Additive preventive effect of influenza and pneumococcal vaccines in elderly persons
Christenson et al.
Eur Respir J 2004;23:363-368.
ABSTRACT | FULL TEXT  

Immunization of Female Mice with Glycoconjugates Protects Their Offspring against Encapsulated Bacteria
Richter et al.
Infect. Immun. 2004;72:187-195.
ABSTRACT | FULL TEXT  

Contemporary Management of Chronic Obstructive Pulmonary Disease: Clinical Applications
Man et al.
JAMA 2003;290:2313-2316.
ABSTRACT | FULL TEXT  

The Conjugate Vaccine and Invasive Pneumococcal Disease
Fedson et al.
NEJM 2003;349:714-716.
FULL TEXT  

Injury Surveillance
Horan and Mallonee
Epidemiol Rev 2003;25:24-42.
FULL TEXT  

Pneumococcal Vaccination and Revaccination of Older Adults
Artz et al.
Clin. Microbiol. Rev. 2003;16:308-318.
ABSTRACT | FULL TEXT  

Failure to Vaccinate Medicare Inpatients: A Missed Opportunity
Bratzler et al.
Arch Intern Med 2002;162:2349-2356.
ABSTRACT | FULL TEXT  

Cost-Effectiveness of the Pneumococcal Vaccine in Healthy Younger Adults
Pepper and Owens
Med Decis Making 2002;22:S45-S57.
ABSTRACT  

Cost-Benefit Analysis of a New HEDIS Performance Measure for Pneumococcal Vaccination
Ahmed et al.
Med Decis Making 2002;22:S58-S66.
ABSTRACT  

Structure-Function Relationships for Human Antibodies to Pneumococcal Capsular Polysaccharide from Transgenic Mice with Human Immunoglobulin Loci
Chang et al.
Infect. Immun. 2002;70:4977-4986.
ABSTRACT | FULL TEXT  

Streptococcus pneumoniae bacteraemia in Belgium: differential characteristics in children and the elderly population and implications for vaccine use
Flamaing et al.
J Antimicrob Chemother 2002;50:43-50.
ABSTRACT | FULL TEXT  

Intranasal Immunization with Pneumococcal Conjugate Vaccines with LT-K63, a Nontoxic Mutant of Heat-Labile Enterotoxin, as Adjuvant Rapidly Induces Protective Immunity against Lethal Pneumococcal Infections in Neonatal Mice
Jakobsen et al.
Infect. Immun. 2002;70:1443-1452.
ABSTRACT | FULL TEXT  

Pneumococcal Conjugate Vaccines Overcome Splenic Dependency of Antibody Response to Pneumococcal Polysaccharides
Breukels et al.
Infect. Immun. 2001;69:7583-7587.
ABSTRACT | FULL TEXT  

Quality Indicators for the Management of Pneumonia in Vulnerable Elders
Rhew
ANN INTERN MED 2001;135:736-743.
FULL TEXT  

Active Immunization in the United States: Developments over the Past Decade
Dennehy
Clin. Microbiol. Rev. 2001;14:872-908.
ABSTRACT | FULL TEXT  

Identification of the psaA Gene, Coding for Pneumococcal Surface Adhesin A, in Viridans Group Streptococci other than Streptococcus pneumoniae
Jado et al.
CVI 2001;8:895-898.
ABSTRACT | FULL TEXT  

Pneumococcal vaccination: current and future issues
Ortqvist
Eur Respir J 2001;18:184-195.
ABSTRACT | FULL TEXT  

Guidelines for the Management of Adults with Community-acquired Pneumonia . Diagnosis, Assessment of Severity, Antimicrobial Therapy, and Prevention
Niederman et al.
Am. J. Respir. Crit. Care Med. 2001;163:1730-1754.
FULL TEXT  

Influence of Patient Age on Streptococcus pneumoniae Serotypes Causing Invasive Disease
Inostroza et al.
CVI 2001;8:556-559.
ABSTRACT | FULL TEXT  

Multidrug-Resistant Streptococcus pneumoniae
Foster et al.
NEJM 2001;344:1329-1331.
FULL TEXT  

Epidemiology of Invasive Streptococcus pneumoniae Infections in the United States, 1995-1998: Opportunities for Prevention in the Conjugate Vaccine Era
Robinson et al.
JAMA 2001;285:1729-1735.
ABSTRACT | FULL TEXT  

Combinatorial Library Cloning of Human Antibodies to Streptococcus pneumoniae Capsular Polysaccharides: Variable Region Primary Structures and Evidence for Somatic Mutation of Fab Fragments Specific for Capsular Serotypes 6B, 14, and 23F
Lucas et al.
Infect. Immun. 2001;69:853-864.
ABSTRACT | FULL TEXT  

Evaluation of Effectiveness of the 23-Valent Pneumococcal Capsular Polysaccharide Vaccine for HIV-Infected Patients
Breiman et al.
Arch Intern Med 2000;160:2633-2638.
ABSTRACT | FULL TEXT  

Immune Function and Vaccine Responses in Healthy Advanced Elderly Patients
Carson et al.
Arch Intern Med 2000;160:2017-2024.
ABSTRACT | FULL TEXT  

A Latex Bead-Based Flow Cytometric Immunoassay Capable of Simultaneous Typing of Multiple Pneumococcal Serotypes (Multibead Assay)
Park et al.
CVI 2000;7:486-489.
ABSTRACT | FULL TEXT  

Influenza and pneumococcal vaccination: patient perceptions
Findlay et al.
Postgrad. Med. J. 2000;76:215-217.
ABSTRACT | FULL TEXT  

Cigarette Smoking and Invasive Pneumococcal Disease
Nuorti et al.
NEJM 2000;342:681-689.
ABSTRACT | FULL TEXT  

Immunogenicity and Tolerance of a 7-Valent Pneumococcal Conjugate Vaccine in Nonresponders to the 23-Valent Pneumococcal Vaccine
Zielen et al.
Infect. Immun. 2000;68:1435-1440.
ABSTRACT | FULL TEXT  

Invasive Pneumococcal Infection in Baltimore, Md: Implications for Immunization Policy
Harrison et al.
Arch Intern Med 2000;160:89-94.
ABSTRACT | FULL TEXT  

The Health and Economic Benefits Associated With Pneumococcal Vaccination of Elderly Persons With Chronic Lung Disease
Nichol et al.
Arch Intern Med 1999;159:2437-2442.
ABSTRACT | FULL TEXT  

Determination of Antibody Responses of Elderly Adults to All 23 Capsular Polysaccharides after Pneumococcal Vaccination
Rubins et al.
Infect. Immun. 1999;67:5979-5984.
ABSTRACT | FULL TEXT  

Intranasal Immunization with Heat-Inactivated Streptococcus pneumoniae Protects Mice against Systemic Pneumococcal Infection
Hvalbye et al.
Infect. Immun. 1999;67:4320-4325.
ABSTRACT | FULL TEXT  

Prognosis After Community-Acquired Pneumonia in the Elderly: A Population-Based 12-Year Follow-up Study
Koivula et al.
Arch Intern Med 1999;159:1550-1555.
ABSTRACT | FULL TEXT  

Pneumococcal Vaccine: An Update
Wadwa
Pediatrics 1999;103:1035-1039.
FULL TEXT  

The place of pneumococcal vaccination
DTB 1998;36:73-76.
ABSTRACT | FULL TEXT  

An Outbreak of Multidrug-Resistant Pneumococcal Pneumonia and Bacteremia among Unvaccinated Nursing Home Residents
Nuorti et al.
NEJM 1998;338:1861-1868.
ABSTRACT | FULL TEXT  

Overwhelming Postsplenectomy Infection in a Patient With Penicillin-Resistant Streptococcus pneumoniae
Machesky and Cushing
Arch Fam Med 1998;7:178-180.
ABSTRACT | FULL TEXT  

Pneumococcal serotypes and their clinical relevance
KALIN
Thorax 1998;53:159-162.
FULL TEXT  

Use of Licensed Vaccines for Active Immunization of the Immunocompromised Host
Pirofski and Casadevall
Clin. Microbiol. Rev. 1998;11:1-26.
ABSTRACT | FULL TEXT  

Long-Term Sequelae of Pneumococcal Meningitis in Children
Pikis et al.
CLIN PEDIATR 1996;35:72-78.
ABSTRACT  

The Prevalence of Drug-Resistant Streptococcus pneumoniae In Atlanta
Hofmann et al.
NEJM 1995;333:481-486.
ABSTRACT | FULL TEXT  

Overwhelming Sepsis and Bleeding in a Previously Splenectomized Patient
Messmore et al.
CLIN APPL THROMB HEMOST 1995;1:80-84.
ABSTRACT  

An Epidemic of Pneumococcal Disease in an Overcrowded, Inadequately Ventilated Jail
Hoge et al.
NEJM 1994;331:643-648.
ABSTRACT | FULL TEXT  

PNEUMOCOCCAL VACCINE HAS VARIED EFFICACY
JWatch General 1993;1993:5-5.
FULL TEXT